...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Promissory Note

..I am showing 53000 shares traded OTC so far today...hummm.

Share
New Message
Please login to post a reply